Severs Disease , also known as calcaneal apophysitis, is a common cause of heel pain in children. It occurs when the growth plate in the child’s heel becomes swollen and painful. Sever’s disease is responsible for heel pain in growing children ages 8-15 years. The heel bone grows rapidly during this period, which results in inflammation where the Achilles tendon attaches to the heel bone. Symptoms include heel pain when walking or running that is usually experienced at the back of the heel. Advanced imaging techniques facilitate an accurate diagnosis of this condition. Treatment options involve rest, exercises, orthotics, night splints, and medications like ibuprofen to reduce inflammation and pain.

The Global Severs Disease Treatment Market is estimated to be valued at US$ 1.34 Bn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Severs disease treatment are AstraZeneca , Horizon Therapeutics plc, Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Cipla Inc., LEO Pharma A/S, AbbVie Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lonza, Lupin, Dr. Reddy’s Laboratories Ltd., IBSA Institut Biochimique SA. Recent technological advancements in diagnostic imaging modalities such as ultrasound and MRI facilitate easy detection of calcaneal apophysitis or Sever’s disease. Ultrasound and MRI scans provide detailed visuals of bone changes and inflammation of the growth plate cartilage that aids accurate diagnosis. Non-surgical treatment methods like immobilization, orthotics, physical therapy made effective through smartphone-based monitoring are expected to drive market growth.

Market Drivers

The key drivers contributing of Severs Disease Treatment Market Size include increasing cases of physical activities and sports injuries among kids and growing awareness about early diagnosis and treatment. As more number of children are participating in sports and rigorous physical training activities at a younger age, the instances of overuse injuries like Sever’s disease are rising. Advanced diagnostic methods help in prompt diagnosis and treatment of the condition before it progresses to a chronic stage. Favorable reimbursement policies for clinically proven treatment options also support the market expansion. Marketing strategies by leading players focusing on newer drug delivery systems and combination therapies will further fuel the Sever’s disease treatment market revenues.

Current challenges in Severs Disease Treatment Market

The current challenges in the Severs Disease Treatment market include lack of awareness about the disease among parents and caregivers, as it usually affects young children and adolescents. As the symptoms are also very mild and resemble normal growing pain, the disease often goes undiagnosed. This poses challenges in effectively treating and managing the condition. Another challenge is the self-limiting nature of the disease, as many cases resolve on their own with time. This discourages proper medical intervention and therapy.

SWOT Analysis

Strength: The treatment options available are fairly effective and include physiotherapy, bracing, oral medication etc. This provides options to manage the condition.

Weakness: The pathogenesis of the disease is not very well understood. This limits targeted treatment approaches.

Opportunity: Improved education programs for parents/caregivers can help raise awareness and diagnosis rates.

Threats: Growing urbanization and sedentary lifestyles are increasing risk factors which can further drive disease incidence rates.

Geographical regions with high market concentration

North America region currently holds the major share of the global Severs Disease Treatment market in terms of value, owing to developed healthcare infrastructure and high diagnosis rates in countries like the US. Europe is another prominent regional market.

Fastest growing region

The Asia Pacific region is expected to witness the highest growth in the Severs Disease Treatment market during the forecast period. This is attributed to factors like rising living standards, growing medical tourism industry and increasing health awareness in developing countries of the region like India and China.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it